» Articles » PMID: 24533741

Argon Gas: a Potential Neuroprotectant and Promising Medical Therapy

Overview
Journal Med Gas Res
Date 2014 Feb 19
PMID 24533741
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Argon is a noble gas element that has demonstrated narcotic and protective abilities that may prove useful in the medical field. The earliest records of argon gas have exposed its ability to exhibit narcotic symptoms at hyperbaric pressures greater than 10 atmospheres with more recent evidence seeking to display argon as a potential neuroprotective agent. The high availability and low cost of argon provide a distinct advantage over using similarly acting treatments such as xenon gas. Argon gas treatments in models of brain injury such as in vitro Oxygen-Glucose-Deprivation (OGD) and Traumatic Brain Injury (TBI), as well as in vivo Middle Cerebral Artery Occlusion (MCAO) have largely demonstrated positive neuroprotective behavior. On the other hand, some warning has been made to potential negative effects of argon treatments in cases of ischemic brain injury, where increases of damage in the sub-cortical region of the brain have been uncovered. Further support for argon use in the medical field has been demonstrated in its use in combination with tPA, its ability as an organoprotectant, and its surgical applications. This review seeks to summarize the history and development of argon gas use in medical research as mainly a neuroprotective agent, to summarize the mechanisms associated with its biological effects, and to elucidate its future potential.

Citing Articles

Positive Effects of Argon Inhalation After Traumatic Brain Injury in Rats.

Antonova V, Silachev D, Plotnikov E, Pevzner I, Ivanov M, Boeva E Int J Mol Sci. 2024; 25(23).

PMID: 39684384 PMC: 11640893. DOI: 10.3390/ijms252312673.


Argon inhalation attenuates systemic inflammation and rescues lung architecture during experimental neonatal sepsis.

Balsamo F, Li B, Chusilp S, Lee D, Biouss G, Lee C Pediatr Surg Int. 2023; 40(1):21.

PMID: 38108911 DOI: 10.1007/s00383-023-05596-7.


Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center.

Simonnet B, Roffi R, Lehot H, Morin J, Druelle A, Daubresse L Front Med (Lausanne). 2023; 10:1172646.

PMID: 37746073 PMC: 10514493. DOI: 10.3389/fmed.2023.1172646.


Argon pharmacokinetics: a solubility measurement technique.

Lemaire J, Heninger M, Louarn E, Katz I, Tissier R, Chalopin M Med Gas Res. 2023; 13(4):208-211.

PMID: 37077120 PMC: 10226686. DOI: 10.4103/2045-9912.351106.


Homeostatic and endocrine responses as the basis for systemic therapy with medical gases: ozone, xenon and molecular hydrogen.

Nazarov E, Khlusov I, Noda M Med Gas Res. 2021; 11(4):174-186.

PMID: 34213500 PMC: 8374457. DOI: 10.4103/2045-9912.318863.


References
1.
David H, Haelewyn B, Degoulet M, Colomb Jr D, Risso J, Abraini J . Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One. 2012; 7(2):e30934. PMC: 3285153. DOI: 10.1371/journal.pone.0030934. View

2.
Zhang M, An C, Gao Y, Leak R, Chen J, Zhang F . Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection. Prog Neurobiol. 2012; 100:30-47. PMC: 3623606. DOI: 10.1016/j.pneurobio.2012.09.003. View

3.
Fowler B, Ackles K, Porlier G . Effects of inert gas narcosis on behavior--a critical review. Undersea Biomed Res. 1985; 12(4):369-402. View

4.
Yang X, Sun P, Qin H, Si P, Sun X, Zhang C . Involvement of MAPK pathways in NMDA-induced apoptosis of rat cortical neurons. Sheng Li Xue Bao. 2012; 64(6):609-16. View

5.
Ristagno G, Fumagalli F, Russo I, Tantillo S, Zani D, Locatelli V . Postresuscitation treatment with argon improves early neurological recovery in a porcine model of cardiac arrest. Shock. 2013; 41(1):72-8. DOI: 10.1097/SHK.0000000000000049. View